MétaCan
Menu
← Back to cohort
Record W4407867059 · doi:10.1681/asn.20233411b3a

MDR-101-MLK Update: Operational Immune Tolerance Achieved in Living Related HLA-Matched Kidney Transplant Recipients

2023· article· en· W4407867059 on OpenAlexaff
Dixon B. Kaufman, Mark D. Stegall, Sanjeev Akkina, James B. Piper, William S. Asch, Stéphan Busque, A. Osama Gaber, Michael E. de Vera, Suzon Collette, Anup Patel, Ashesh P. Shah, Erik Stites, Lenuta Micsa, Daniel C. Brennan

Bibliographic record

VenueJournal of the American Society of Nephrology · 2023
Typearticle
Languageen
FieldMedicine
TopicRenal Transplantation Outcomes and Treatments
Canadian institutionsHôpital Maisonneuve-Rosemont
Fundersnot available
KeywordsKidney transplantImmune systemKidney transplantationMedicineHuman leukocyte antigenImmunologyRenal transplantKidneyInternal medicineAntigen

Abstract

fetched live from OpenAlex

Background: We describe the updated results from a Phase 3 RCT in recipients of HLA-matched living donor (LD) kidney transplants (KTxp) who received investigational cellular product, MDR-101, for induction of immune tolerance and elimination of immunosuppressive (IS) drugs vs standard of care (SOC) (NCT03363945). Methods: Eligible adult, recipients (R) of a 1st kidney from an HLA-matched related LD were randomized 2:1 to Investigational Arm (IA; n=20) or Control Arm (CA; n=10). Peripheral blood CD34+ and CD3+ cells for MDR-101 were collected via apheresis from the same kidney donor. IA-Rs were transplanted day (D) 0 and received rATG (D0-4), total lymphoid irradiation (10 fractions), initiation of CNI, followed by an MDR-101 infusion (D11). Steroids were withdrawn by D10 and MMF was given D11-D39. CNI monotherapy continued till D180 and tapered to complete withdrawal 1-year post-transplant (tx) if donor hematopoietic mixed chimerism was ≥5%, and no rejection (BPAR), GvHD, or kidney loss. CA-Rs received IS per institutional SOC. Results: 20 IA-Rs received tolerance induction conditioning including MDR-101 infusion. 1 IA-R not an HLA-matched (a protocol deviation) and <6 mos of chimerism did not qualify for IS withdrawal. 19 IA-Rs successfully discontinued IS 1-year post-tx. To date, the number of IA-Rs and time remaining off IS: for 12 mos (n=17/19), 12-24 mos (n=17/19), 24 mos (n=12/14). 4 IA-Rs remain off IS and are yet to reach 24 mos off IS. 3 IA-Rs resumed IS: recurrent IgAN (18.7 mos off IS), recurrent IgAN and rejection (4.8 mos off IS), and rejection (11.2 mos off IS). No GvHD, PTLD or other malignancies occurred. No death occurred in either group. 1 IAR developed recurrent IgAN and after study completion had graft loss (4.3 years post-tx). D365 mean eGFR was 64.37 mL/min (IA-R) and 58.78 mL/min (CA-R). D730 mean eGFR was 62.37 mL/min (IA-R) and 62.22 mL/min (CA-R). Conclusions: MDR-101 can safely achieve donor mixed chimerism and operational immune tolerance with complete elimination of all IS with no death, graft loss, or GvHD in HLA-matched LD recipients. The protocol anticipated treatment success of at least 48% IA-R IS-Free for at least 24 mos was met.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.007
metaresearch head score (Gemma)0.005
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.007
Threshold uncertainty score0.037

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0070.005
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0020.003
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0020.001
Open science0.0010.001
Research integrity0.0010.002
Insufficient payload (model declined to judge)0.0050.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.015
GPT teacher head0.285
Teacher spread0.270 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2023
Admission routes1
Has abstractyes

Explore more

Same venueJournal of the American Society of Nephrology→Same topicRenal Transplantation Outcomes and Treatments→French-language works237,207→